Skip to content
Review Open access

RNA as a crowding agent.

Aug 2026 · Current Opinion in Structural Biology · Vol 101, pp. 103356 · 0 citations · 68 references
Medicine

TL;DR

This minireview examines how RNA shapes the formation, composition, and material properties of biomolecular condensates, highlighting the molecular grammar encoded in RNA sequence, length and valency, structure, and chemical modifications.

Abstract

The crowded intracellular milieu shapes the thermodynamics and kinetics of biochemical reactions. RNA, an abundant and structurally versatile polymer, contributes to this crowding by acting both as a physical agent that restricts diffusion and enhances excluded volume, and as a sequence- and structure-specific scaffold driving multivalent RNA-RNA and RNA-protein interactions. These properties position RNA as a biologically active determinant of intracellular organization, distinct from inert synthetic crowders and purely structural scaffolds. This minireview examines how RNA shapes the formation, composition, and material properties of biomolecular condensates, highlighting the molecular grammar encoded in RNA sequence, length and valency, structure, and chemical modifications. We discuss how concentration-dependent, biphasic effects of RNA on condensate assembly can tip the balance between functional compartmentalization and pathological liquid-to-solid transitions implicated in neurodegenerative disease and cancer. Finally, we outline challenges in defining RNA-specific thresholds and translating structural insights into therapeutic strategies for mitigating aberrant RNA-mediated crowding.

Read PDF

Similar papers

Review Jul 2026

Physicochemical principles of RNA-mediated crowding.

This work examines the physicochemical principles underlying RNA-mediated crowding, focusing on how sequence-driven multivalency, structural topology, and network connectivity govern molecular organization.

Jonathan Fiorentino, Michele Monti, Laura Broglia et al. · 0 citations
Review Jul 2026

How crowding shapes protein aggregation.

Crowding-aware structural biology, including in-cell nuclear magnetic resonance, cryo-electron microscopy of condensates, single-molecule methods, and thermodynamic-kinetic modelling, will be important for resolving physiologically relevant intermediates.

Tejas Nikam, Shashi Prakash Patel, S. Saraf et al. · 1 citation
Review Open access Aug 2026

Probing the complexity of cellular RNA folding: Ensembles, intermediates, and isoforms.

Recent advances in RNA chemical probing, sequencing, and computational deconvolution technologies are reviewed, and how resolving RNA structural ensembles with increasingly high resolution will likely reveal new therapeutic opportunities to selectively target functional RNA heterogeneity is discussed.

Anthony M. Mustoe, D. Incarnato · 0 citations
Open access Jul 2026

Single-molecule mass measurements uncover shifting RNA interactions during condensate phase transitions

It is demonstrated that single-molecule mass measurements with mass photometry can capture RNA-protein interactions in phase-separated protein systems and can distinguish between charge neutralization, which drives coacervation, and complex formation, which mediates phase re-entry, making it a highly complementary tool...

Axel Leppert, Jesper Shiapan, Irena Papageorgiou et al. · 0 citations
Jul 2026

Diverse Roles of Nucleotides in Tuning Metal-Ion-Stabilized Intermediates of Amino Acid Aggregate via Phosphate Multiplicity and Salt-Triggered Fusion.

Supramolecular assemblies regulated by small biomolecules, such as nucleotides, provide key insights into biological organization, particularly in protein aggregation, which is linked to neurodegenerative diseases. While the role of nucleotides as a stabilizer and biological hydrotrope is well-established, their intera...

Suman Choudhury, Priyanka Nath, Huma Tabassum et al. · 0 citations
Open access Aug 2026

Aminoglycoside antibiotics drive RNA phase separation

It is shown that aminoglycosides are a class of small-molecule RNA condensers, and neomycin B (neoB), an FDA-approved member of the family, is taken as a representative drug through which to dissect the mechanism.

Julian von Hofe, Mechi Chen, Christine Choi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.